European Archives - Page 885 of 912 - European Medical Journal

Continue
29th September 2014

Review: Genetics of Urolithiasis

Urolithiasis constitutes a worldwide health problem with a frequency of up to 15% in the general population.
24th September 2014

Review: Evolution of Minimally Invasive Radical Prostatectomy – A Continuous Development

During the last 15 years, minimally invasive surgery has been introduced gradually in surgical treatment for prostate cancer (CaP).
EMJ
3 Mins
23rd September 2014

Stigma is a Side-Effect of HIV Prevention Medicine

100,000 people are living with HIV within the UK, and one-quarter of these are undiagnosed. This is not only within the capital; latest research suggests…
September 2014

EMJ Hepatology 1[Suppl 1] 2014

The main objective of chronic hepatitis C virus (HCV) management is to provide high viral eradication rates with acceptable toxicity.
EMJ
6 Mins
22nd September 2014

European Commission Grants Marketing Authorisation for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia and Follicular Lymphoma

Foster City, CA, 19 September 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted marketing…
19th September 2014

Can Primary Care Physicians Manage Benign Prostatic Hyperplasia Patients As Urologists Do?

Most clinical practice guidelines (CPGs) assume that general practitioners (GPs) can manage non- complicated benign prostatic hyperplasia (BPH)-related…
11th September 2014

A Very Rare Entity of Benign Prostatic Inflammation: Xanthogranulomatous Prostatitis

Prostatitis is a commonly seen clinical entity in daily urological practice.
EMJ
8th September 2014

Advancements and Updates in the Field of Enuresis

Summary of the Enuresis Lecture, held at the 25th Annual ESPU Congress, Innsbruck, Austria, on 9th May 2014
EMJ
September 2014

EMJ Urology 1 [Suppl 1] 2014

Dr Austin’s presentation aimed to provide a state-of-the-art review on enuresis, focusing on diagnosis, treatment strategies, and management of…
EMJ
5th September 2014

Update: Diagnosis and Treatment of Muscle-Invasive and Metastatic Bladder Cancer in 2014

Bladder cancer (BC) is the ninth most commonly diagnosed malignant tumour in the world, with an incidence of about 356,000 and a mortality of about 145,000 per year in both non-muscle-invasive and muscle-invasive BC.